Targeted therapies for bone regeneration
We are commercializing a small molecule-based osteoinductive platform technology to develop bone growth products that activate a novel molecular pathway.
Discovered serendipitously, Zetagen'sTM products have the potential to transform the treatment of bone-related injuries, procedures and diseases to deliver better outcomes for patients, doctors and payors.
We are grateful for the support we have received to date from several groups including:
© 2019 Zetagen Therapeutics Inc. All rights reserved.